“仿生内控”治疗晚期癌症的临床应用报告

仿生内控治疗（BICT）恶性肿瘤是建立在“恶性肿瘤投影学说——一种研究癌症的新理论”的基础上，该理论认为癌症是一种细胞病，是一种细胞分化信息调控障碍性疾病。在此理论指导下，研究了仿生内控治疗恶性肿瘤的方法，该方法为一组药物治疗，包括复新液、归正胶囊、绿波胶囊三种。在证明了该方法的有效性和安全性的基础上，用该方法对17种、1068例晚期恶性肿瘤患者进行临床治疗观察。结果显示该方法抗癌谱广，重复性好，具有显著的控制肿瘤生长和临床减痛疗效，患者生活质量提高，肿瘤缩小或消失。因此仿生内控治疗恶性肿瘤是安全有效的，是一种全新的文档顶端、无损伤的治疗癌症方法，给肿瘤患者提供了又一新的选择。

Application of bionic internal control treatment for on malignant cancer

The method of Bionic Internal Control Treatment(BICT)is based on a theory of"Projec- tion theory of cancer".According to the theory,cancer is kind of a cell disease,on the other hand,it is a disease resulted from the confused cell information controlling.BICT uses a group of drugs including FUXING liquid,GUIZHENG capsule,and LVBO capsule.On the basis of safety and efficiency,we have observed 1068 patients involving 17 different cancers.After measuring the main organs and observing chan- ging of clinical symptoms and signs,tissue pathology,CT,ECT,and blood biochemical and Cancer mark- ers,this method showed capabitity in prolong life and improve life quality,and finally the size of cancer can be reduced or even disappear.Conclusion Using BICT to cure cancer is safe and efficient.